- Home
- OST vs SILO Comparison
OST vs SILO Comparison
Compare OST & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- SILO
- Stock Information
- Founded
- OST 2010
- SILO 2010
- Country
- OST China
- SILO United States
- Employees
- OST N/A
- SILO N/A
- Industry
- OST Industrial Machinery/Components
- SILO Apparel
- Sector
- OST Technology
- SILO Consumer Discretionary
- Exchange
- OST Nasdaq
- SILO Nasdaq
- Market Cap
- OST 4.3M
- SILO 4.7M
- IPO Year
- OST 2022
- SILO N/A
- Fundamental
- Price
- OST $2.37
- SILO $1.96
- Analyst Decision
- OST
- SILO
- Analyst Count
- OST 0
- SILO 0
- Target Price
- OST N/A
- SILO N/A
- AVG Volume (30 Days)
- OST 2.1M
- SILO 9.0M
- Earning Date
- OST 01-29-2025
- SILO 02-14-2025
- Dividend Yield
- OST N/A
- SILO N/A
- EPS Growth
- OST N/A
- SILO N/A
- EPS
- OST N/A
- SILO N/A
- Revenue
- OST $38,203,634.00
- SILO $72,102.00
- Revenue This Year
- OST N/A
- SILO $1.86
- Revenue Next Year
- OST N/A
- SILO N/A
- P/E Ratio
- OST N/A
- SILO N/A
- Revenue Growth
- OST N/A
- SILO N/A
- 52 Week Low
- OST $1.60
- SILO $0.77
- 52 Week High
- OST $7.41
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- OST 52.74
- SILO 79.84
- Support Level
- OST $2.24
- SILO $1.62
- Resistance Level
- OST $4.42
- SILO $2.16
- Average True Range (ATR)
- OST 0.61
- SILO 0.31
- MACD
- OST 0.03
- SILO 0.10
- Stochastic Oscillator
- OST 19.29
- SILO 43.37
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.